Gilead Sciences Raises FY Guidance Due To Remdesivir Sales

Gilead Sciences CEO remdesivir sales

CNBC Exclusive: CNBC Transcript: Gilead Sciences Chairman & CEO Daniel O’Day speaks with CNBC’s “Squawk Box” today about raising full-year guidance due to remdesivir sales. Q3 2020 hedge fund letters, conferences and more   Gilead Sciences CEO On Raising Full-Year Guidance Due To Remdesivir Sales   MEG TIRRELL: Dan, thanks for being with us this […]

The post Gilead Sciences Raises FY Guidance Due To Remdesivir Sales appeared first on ValueWalk.

Read More

Five reasons why your coronavirus stimulus check might be delayed

Coronavirus, stimulus check, reasons

Stimulus checks started going out earlier this month and millions of eligible people have already received their money. If you haven’t yet received your coronavirus stimulus check or the status of your payment is not available, then there could be several reasons for it. It is better that you understand these possible reasons and then […]

The post Five reasons why your coronavirus stimulus check might be delayed appeared first on ValueWalk.

Read More

Elon Musk’s Wealth Has Grown Almost Seven-Fold

Musk Wealth

Musk overtakes Bezos as the richest person in the world as billionaires continue to grow wealthier during pandemic Q3 2020 hedge fund letters, conferences and more Musk’s Wealth Has Grown $163 Billion—Almost 7-Fold—Over Past 10 Months The Growth In Elon Musk’s Wealth WASHINGTON, D.C. – Elon Musk, the billionaire CEO of Tesla and SpaceX, is […]

The post Elon Musk’s Wealth Has Grown Almost Seven-Fold appeared first on ValueWalk.

Read More

2020 ends with an ILS whimper, as rates go sideways: Lane Financial

As expected, the catastrophe bond hard market persisted through the final quarter of 2020, but the year “went out with an ILS whimper” according to consultancy Lane Financial, as insurance-linked security (ILS) rates-on-line went sideways. Catastrophe bond and insurance-linked security (ILS) rates-on-line remained flat through the fourth-quarter of 2020, the latest analysis from ILS focused…

Read More

Mars Inc. interested in alternative reinsurance capital & parametrics: de Wolfe

Mars Incorporated, an American company which is one of the largest globally active and multinational manufacturers of food products, confectionery and pet food, has said that alternative capital is attractive to the firm as a potential backer for its captive, whole parametric risk transfer is seen as a “fantastic” risk management tool. This is according…

Read More

Gallagher Re secured $140m of reinsurance for Arch’s Bellemeade program in 2020

Global reinsurance broker Gallagher Re, part of the Gallagher group, successfully brokered $140 million of traditional mortgage reinsurance for Arch Capital during 2020, as part of the firms Bellemeade Re mortgage insurance-linked securities (ILS) program. Arch Mortgage Insurance sponsored the issuance of over $1.55 billion of Bellemeade Re mortgage insurance-linked notes in 2020, as it…

Read More

QBE lifts cat reinsurance tower to $3.4bn, pays slightly more for it

Australia headquartered global insurance and reinsurance firm QBE has increased the top of its main catastrophe reinsurance tower to $3.4 billion, with the company saying its renewal came in at a premium rate increase of under 5%, but restructured things slightly to account for heightened catastrophe frequency. QBE said this morning that its January 2021…

Read More

ILS outlook for 2021 positive, as yields move higher: Ruoff, Schroder Secquaero

The insurance-linked securities (ILS) market has entered 2021 with a positive outlook, as ILS investment yields have moved to some of the most attractive levels seen in almost a decade, according to Stephan Ruoff, Head of Schroder Secquaero. Following a number of years where ILS investment returns have been challenged by catastrophe losses, loss creep…

Read More